Small Molecule Inhibition of GSK-3 Specifically Inhibits the Transcription of Inhibitory Co-receptor LAG-3 for Enhanced Anti-tumor ImmunityChristopher E. Rudd, Alison Taylor|Cell Reports|2020Cited by 74
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cellsGary Shaw, Alison Taylor|Journal of Hematology & Oncology|2022Cited by 46